Content about Dyskinesia

June 9, 2011

Patients with Parkinson’s disease treated with an investigational drug made by Abbott saw a decrease in the amount of time their symptoms resurfaced, while the time in which their symptoms stayed under control increased, according to results of a late-stage clinical trial that Abbott announced Thursday.

© 2014 Drug Store News. All Rights Reserved.